Scabies

Reading File
Finding Sources
Searching PubMed

scabies treatment management

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Loading Image
I have comprehensive content from Fitzpatrick's and Rosen's. Let me now compile the full answer.

Scabies

A parasitic skin infestation caused by Sarcoptes scabiei var. hominis - a host-specific mite that completes its entire life cycle within human epidermis. Globally, an estimated 150-200 million people are affected, with a worldwide prevalence of ~2.5%. In 2017, the WHO designated it a neglected tropical disease.

Aetiology & Pathogen

The mite belongs to class Arachnida, family Sarcoptidae. Key facts:
  • Adult female: 0.4 x 0.3 mm - just too small to see with the naked eye
  • Pearl-like, translucent, white, oval, with 4 pairs of short stubby legs
  • Can survive 3 days off a host (up to 7 days in mineral oil)
  • Cannot fly or jump
Life cycle (completed entirely on skin, ~30 days):
  1. Female excavates a burrow in the stratum corneum at 0.5-5 mm/day, reaching the stratum granulosum boundary
  2. She lays 2-4 eggs/day (up to 50 over her 30-day lifespan)
  3. Eggs hatch in 10-12 days; larvae mature on skin surface
  4. Larvae molt into nymphs, nymphs into adults
  5. Male lives on skin surface, enters burrows to copulate
A normal host harbours 3-50 mites (average fewer than 20).
  • Fitzpatrick's Dermatology, Vol. 1-2, p. 3303-3304

Transmission

  • Primary: close personal contact (skin-to-skin) - sexual or non-sexual
  • Fomites: less common in classic scabies; very important in crusted scabies (thousands of mites/gram of debris from bedding, floors, furniture)
  • Equally prevalent in children and sexually active adults - nonsexual household transmission is just as effective

Clinical Features

Incubation: 4-6 weeks after first infestation (some patients up to 3 months; a few never sensitize). On re-infestation, symptoms appear within 2-3 days.
Cardinal symptom: intense nocturnal pruritus
Distribution of lesions (spares head/neck in healthy adults):
  • Interdigital webs of hands
  • Sides of fingers, volar wrists, lateral palms
  • Elbows, axillae
  • Scrotum, penis, labia, areolae
  • Buttocks, abdomen
In infants, elderly, and immunocompromised: all surfaces including face, scalp, palms, and soles are affected.
Primary lesion: The burrow - a 1-cm, thread-like, sinuous track in the skin, most visible in finger webs.
Burrows in finger web spaces - Fitzpatrick's Dermatology
Thread-like burrows in the web spaces of the fingers - a classic scabies finding (Fitzpatrick's Dermatology)
Other lesions: papules, pustules, vesicles, excoriations, eczematous dermatitis.

Crusted (Norwegian) Scabies

A severe, highly contagious variant. Patients harbour thousands to millions of mites.
Risk groups:
  • HIV/AIDS, HTLV-1 infection
  • Solid organ transplant recipients
  • Elderly, dementia patients
  • Leprosy, paraplegia (impaired sensory function or inability to scratch)
  • Systemic glucocorticoid use
Features: Hyperkeratotic, thick, crusted plaques (especially palms and soles), nail thickening and dystrophy, minimal pruritus despite massive infestation.
Crusted scabies with hyperkeratotic facial plaques - Fitzpatrick's Dermatology
Crusted scabies: hyperkeratotic plaques populated with thousands of mites (Fitzpatrick's Dermatology)
Anyone in the vicinity of a crusted scabies patient risks infestation - environmental contamination is extensive.

Diagnosis

Primarily clinical - based on history (nocturnal itch, contacts affected), characteristic distribution, and epidemiology.
Definitive confirmation:
  1. Skin scraping: Drop mineral oil on burrow → scrape longitudinally with a #15 scalpel blade → apply to glass slide → examine under low power for mites, eggs, or fecal pellets (scybala). Do not scrape excoriated areas.
  2. Dermoscopy: The classic finding is the "delta-wing jet" sign - dense scabies head parts + translucent body + eggs + S-shaped burrow
  3. Skin biopsy: May reveal mite transected in the stratum corneum (histopathology)
  4. Confocal microscopy: In vivo examination of the mite
No serologic test exists for scabies in humans.
In the emergency setting, treatment can be started on clinical suspicion alone without waiting for confirmation.

Differential Diagnosis

ConditionDistinguishing feature
Atopic dermatitisPersonal/family atopy history, no burrows
Contact dermatitisExposure history, patch test
Papular urticariaInsect bite history, no interdigital pattern
Pityriasis roseaHerald patch, Christmas tree distribution
Secondary syphilisSymmetric maculopapular rash, serology
FolliculitisPerifollicular, no burrows
Lichen planusViolaceous polygonal papules on extremities
PsoriasisSilvery scale, plaques, nail changes
Dermatitis herpetiformisAutoimmune, celiac association, blistering

Complications

  • Secondary bacterial infection (impetiginization) with Streptococcus pyogenes or Staphylococcus aureus
  • Post-streptococcal glomerulonephritis from scabies-induced pyoderma
  • Lymphangitis and septicemia (especially in crusted scabies)
  • Bullous pemphigoid - scabies infestation can trigger this autoimmune blistering condition
  • Fitzpatrick's Dermatology, Vol. 1-2, p. 3305

Treatment

Principles

  • Treat the patient and all household contacts/close contacts simultaneously, even if asymptomatic
  • A second application at 1-2 weeks is required to kill nymphs that hatched after initial treatment
  • Fomite control (wash clothing, bedding, towels in hot water; items that cannot be washed should be sealed in a plastic bag for 1 week)

First-line: Permethrin 5% Cream

  • Apply from neck down to entire body, including under nails, umbilicus, nipples, genitals
  • In infants and young children: treat face and scalp as well
  • Apply at bedtime; wash off after 8-12 hours
  • Repeat in 1-2 weeks

Oral Ivermectin

  • Off-label in many countries but widely used
  • Standard: 200 mcg/kg as a single dose, repeated at 2 weeks
  • Cure rate may be slightly lower than permethrin with a single dose
  • For crusted scabies or heavily infested/immunocompromised patients: multiple doses recommended (e.g., days 1, 2, 8, 9, 15 with concurrent topical therapy)
  • Not recommended in pregnancy, breastfeeding, or children <5 kg

Alternative Topical Agents

AgentNotes
Lindane 1% lotionNo longer preferred (neurotoxicity risk; contraindicated in infants, children, pregnant women)
Sulfur 5-10% in petrolatumSafe in pregnancy and infants <2 months; less cosmetically acceptable
Benzyl benzoate 10-25%Used widely in resource-limited settings
Crotamiton 10%Lower efficacy; used when others are contraindicated

Symptomatic Relief

  • Topical or oral corticosteroids for post-scabetic itch (pruritus can persist 2-4 weeks after successful treatment due to ongoing hypersensitivity reaction - this does not indicate treatment failure)
  • Oral antihistamines for itch
  • Topical/oral antibiotics if secondary impetiginization present
  • Fitzpatrick's Dermatology, Vol. 1-2, p. 3305-3306; Rosen's Emergency Medicine, p. 2411-2412

Special Populations

PopulationConsideration
Infants (<2 months)Sulfur 5% ointment preferred; permethrin not approved
PregnancySulfur ointment safest; permethrin Category B - generally acceptable
Immunocompromised/crustedCombined oral ivermectin + topical permethrin; multiple treatment courses
ElderlyHigher risk of crusted variant; may have atypical presentation
HIV patientsCrusted scabies; immune reconstitution may bring out symptoms

Environmental Control

  • Wash all worn clothing, bedding, towels in hot water (>50°C) and dry on high heat
  • Items that cannot be washed: seal in plastic bag for 72 hours (classic scabies) or 1 week (crusted scabies)
  • Vacuum furniture and floors; more important for crusted scabies
  • Spraying insecticides on surfaces is generally not recommended for classic scabies

Key take-aways for exam and clinical practice:
  1. Nocturnal itch + interdigital burrows = scabies until proven otherwise
  2. Treat all contacts simultaneously or re-infestation is virtually guaranteed
  3. Itch persisting for weeks after treatment ≠ treatment failure (it is hypersensitivity)
  4. Crusted scabies: consider in any immunocompromised patient with hyperkeratotic skin changes and minimal itch
  5. Post-scabetic nodules on the scrotum/areolae can persist for months - they are a granulomatous reaction and do not indicate active infestation
Sources: Fitzpatrick's Dermatology (9th ed.), Rosen's Emergency Medicine (10th ed.), Dermatology 2-Volume Set (5th ed., Bolton & Griffiths), Goldman-Cecil Medicine

Pitriyasis rosea

Finding Sources
Searching PubMed

pityriasis rosea

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Loading Image
Reading File
Loading Image
I now have all the content I need. Let me compile the comprehensive answer.

Pityriasis Rosea

A common, self-limited papulosquamous eruption first described by Gibert in 1860. The name means "pink scales" (rosea = pink, pityriasis = scales). It is a clinical diagnosis in most cases and almost always resolves on its own within 5-12 weeks.

Epidemiology

  • Worldwide distribution; affects all races and ethnic groups
  • Peak incidence: ages 10-35 years (range 3 months to 83 years)
  • Slight female predominance (ratio ~1.39:1)
  • Incidence: ~0.64 per 100 dermatologic patients; up to 3-30 per 1,000 patients by some reports
  • May show seasonal variation (spring and fall), though not universally confirmed
  • Case clustering has been documented, supporting an infectious aetiology
  • Relapse is rare (1.8-3.7% of cases)
  • Fitzpatrick's Dermatology (9th ed.), Ch. 31

Aetiology & Pathogenesis

The precise cause remains unknown, but the leading hypothesis is a viral exanthem. Evidence strongly implicates Human Herpesvirus 7 (HHV-7) and, to a lesser extent, HHV-6, through either primary infection or viral reactivation.
Supporting evidence:
  • HHV-7 DNA and mRNA detected in lesional and non-lesional skin, peripheral blood mononuclear cells, and cell-free plasma of PR patients
  • HHV-7 viremia demonstrated during active PR
  • Case clustering and possible seasonal variation are consistent with an infectious trigger
  • Resemblance to other known viral exanthems
  • Prodromal symptoms in up to 69% of patients
Other investigated causes (bacterial, fungal) have been largely ruled out. The current model is that PR represents a reactivation of latent HHV-6/HHV-7 that triggers a viremia and subsequent cutaneous eruption.
  • Fitzpatrick's Dermatology (9th ed.), Ch. 31; Tintinalli's Emergency Medicine (9th ed.)

Clinical Features

Two-Phase Presentation

Phase 1 - The Herald (Mother) Patch:
  • Present in ~80% of cases (range: 12-94%)
  • A single, well-demarcated, oval to round plaque
  • Color: pink, rose, erythematous, or less commonly hyperpigmented
  • Size: 2-10 cm (usually >3 cm)
  • Has a slightly depressed centre with a fine "collarette" of scale - characteristically with the open edge of scale pointing inward (toward the centre)
  • Most common on the trunk (50%), also on extremities and neck
  • In adults: remains isolated for ~2 weeks before the secondary eruption
  • In children: interval is shorter, only ~4 days
Herald patch of pityriasis rosea - large erythematous oval plaque with central scale (Goldman-Cecil Medicine)
Herald patch: large erythematous oval patch - the initial and most distinctive lesion of pityriasis rosea (Goldman-Cecil Medicine)
Phase 2 - Secondary Eruption:
  • Begins ~2 weeks after the herald patch
  • Numerous smaller (1-2 cm), oval papules and plaques with the same fine collarette of scale
  • Distributed on trunk and proximal extremities
  • Their long axes run parallel to the lines of skin cleavage (Langer's lines) - on the back, this produces the classic "Christmas tree" distribution
  • Palms, soles, and face typically spared (in adults)
Pityriasis rosea - secondary oval lesions on trunk (Rosen's Emergency Medicine)

Symptoms

  • Pruritus: severe in 25%, mild-to-moderate in 50%, absent in 25%
  • Prodromal/systemic symptoms (malaise, headache, nausea, upper respiratory, GI symptoms): present in 5-69% of patients, may precede or accompany the rash
  • Lymphadenopathy: may occur with flu-like symptoms

Mucosal Involvement

Oral lesions are uncommon but occur in up to 16% of cases. Morphologies include:
  • Punctate hemorrhagic lesions
  • Ulcerations (most common oral form)
  • Erythematous macules or plaques
  • Bullous or annular lesions

Atypical Variants (~20% of cases)

VariantFeatures
Inverse PRInvolves body folds, face, distal extremities; more common in children
Localized PRLimited to one truncal site
Unilateral PRDoes not cross the midline
Vesicular/papularVesicular or papular morphology; more common in children and young adults
Purpuric PRPurpuric lesions (see image below)
Blaschkoid PRDistribution follows Blaschko's lines
Relapsing PRSingle relapse within 1 year; subsequent episode usually lacks herald patch, is shorter and more localized
Persistent PRDuration >12 weeks; oral lesions more common
Pediatric PRShorter herald-to-secondary interval (4 days), shorter overall course (~16 days avg.)

Natural Course & Duration

  • Self-limited: resolves in 4-16 weeks (typically 6-8 weeks in most sources)
  • Resolves without scarring in immunocompetent individuals
  • Recurrences are rare
  • No long-term complications in healthy individuals

Pregnancy

PR during pregnancy deserves special attention:
  • Occurs more frequently in pregnant women than the general population
  • In one study of 38 pregnant women with PR: 13% miscarriage rate (vs ~10% baseline)
  • Of 8 cases beginning before 15 weeks gestation: 62% resulted in abortion
  • 27% premature delivery rate (but no birth defects reported)
  • 18% of infants showed hypotonia, weak motility, or hyporeactivity
  • Recommendation: Pregnant women with PR, especially in the first trimester, should be followed carefully for adverse outcomes.

Diagnosis

Primarily clinical based on the characteristic two-phase presentation.
Helpful diagnostic clue: collarette of scale with the free edge pointing inward.
Key investigation to always consider: RPR/VDRL to rule out secondary syphilis - which can look almost identical. Secondary syphilis is the most important differential to exclude, especially if palms and soles are involved.
Histopathology (not usually needed):
  • Spongiosis with mild acanthosis
  • Focal parakeratosis
  • Lymphocytic exocytosis
  • Perivascular lymphohistiocytic infiltrate
  • Extravasated erythrocytes (in purpuric variant)

Differential Diagnosis

ConditionHow to distinguish from PR
Secondary syphilisInvolves palms/soles; serology positive; no herald patch
Guttate psoriasisNo collarette scale; no herald patch; Auspitz sign
Tinea corporisKOH positive; central clearing; no Christmas tree pattern
Drug eruptionDrug exposure history; no herald patch; drug-induced PR mimics: captopril, lisinopril, clonidine, gold, imatinib, interferon, barbiturates
Lichen planusViolaceous, polygonal papules; Wickham's striae
Atopic dermatitisFlexural distribution; personal/family atopy; chronic relapsing
Viral exanthemOften symmetric; lacks collarette scale
Tinea versicolorKOH shows hyphae/spores; lacks collarette scale
Note: Several medications cause a pityriasis rosea-like eruption (drug-induced PR): captopril, barbiturates, lisinopril, ketotifen, arsenicals, interferon, imatinib, gold, clonidine.

Treatment

PR is self-limited and most patients require only reassurance and symptomatic therapy.

Symptomatic / First-line

  • Oral antihistamines - for pruritus
  • Topical corticosteroids (e.g., triamcinolone 0.1% cream) - for pruritus and inflammation
  • Emollients (petroleum jelly-based preparations)
  • Topical zinc oxide or calamine lotion - particularly useful in the ED setting
  • Natural sunlight or UVB phototherapy - may speed resolution of lesions

Antiviral (for severe/widespread disease)

  • Oral acyclovir - has shown benefit in hastening recovery and lessening symptoms in patients with severe or widespread eruption. Several studies support its use but evidence is not definitive.
    • Typically: acyclovir 800 mg 5x/day for 1 week

What is NOT indicated

  • Macrolides (erythromycin) - earlier studies suggested benefit but more recent data do not support use
  • Systemic steroids: generally not indicated; may be used cautiously in very severe or vesicular cases
  • No isolation or activity restrictions are needed
  • Fitzpatrick's Dermatology (9th ed.), Ch. 31; Tintinalli's Emergency Medicine (9th ed.); Rosen's Emergency Medicine (10th ed.)

Key Points for Exam & Clinic

  1. Herald patch precedes the secondary eruption by ~2 weeks (adults) - present in 80% of cases
  2. The Christmas tree pattern on the back reflects alignment of oval plaques along skin cleavage lines
  3. The collarette of scale with the free edge pointing inward is a hallmark - opposite to tinea where scale points outward
  4. Always order VDRL/RPR - secondary syphilis is the #1 differential, especially if palms/soles involved
  5. Self-limited - reassurance is the most important part of management
  6. HHV-6/HHV-7 reactivation is the leading aetiologic hypothesis
  7. Pregnancy + first trimester = higher risk of miscarriage; counsel and monitor carefully
  8. Drug-induced PR should be considered in all cases - review the medication list
Sources: Fitzpatrick's Dermatology Vol. 1-2 (9th ed.), Goldman-Cecil Medicine (International ed.), Rosen's Emergency Medicine (10th ed.), Tintinalli's Emergency Medicine (9th ed.)
This is a shared conversation. Sign in to Orris to start your own chat.